Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands
Texas
77381-1160
United States
Tel: 281-863-3000
Fax: 281-863-8088
Website: http://www.lexpharma.com/
415 articles about Lexicon Pharmaceuticals, Inc.
-
Lexicon Pharmaceuticals, Inc. Release: LX4211 for Diabetes Shown to Reduce Fasting and Post-Prandial Blood Sugar in Healthy Subjects
9/13/2011
-
Lexicon Pharmaceuticals, Inc. Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting
9/13/2011
-
Lexicon Pharmaceuticals, Inc. to Present at Morgan Stanley Global Healthcare Conference
9/6/2011
-
Lexicon Pharmaceuticals, Inc. to Present at Stifel Nicolaus Healthcare Conference
8/30/2011
-
Lexicon Pharmaceuticals, Inc. to Present at the Wedbush 2011 Life Sciences Management Access Conference
8/12/2011
-
Lexicon Pharmaceuticals, Inc. Announces Publication of Results From the Phase 2 Trial of LX1031 in Patients With Irritable Bowel Syndrome in Journal of Gastroenterology
8/11/2011
-
Phase 2 Trial of Lexicon Pharmaceuticals, Inc.'s LX1032, Telotristat Etiprate, Shows Positive Results in Carcinoid Syndrome
8/9/2011
-
Lexicon Pharmaceuticals, Inc. Reports on Clinical Program Status and 2011 Second Quarter Results
8/9/2011
-
Lexicon Pharmaceuticals, Inc. to Provide Clinical Pipeline Update and Report Second Quarter 2011 Financial Results
8/5/2011
-
Lexicon Pharmaceuticals, Inc.'s IBS Drug Candidate, LX1033, Successfully Completes Phase 1 Clinical Trial
7/28/2011
-
Lexicon Pharmaceuticals, Inc. Presents LX4211 Mechanism of Action Data at American Diabetes Association Meeting and Announces Commencement of Phase 2b Clinical Trial in Type 2 Diabetes
6/27/2011
-
Lexicon Pharmaceuticals, Inc. to Present at the Jefferies and Co. 2011 Global Healthcare Conference
6/1/2011
-
Lexicon Pharmaceuticals, Inc. Announces Webcast of 2011 Annual R&D Day
5/9/2011
-
Lexicon Pharmaceuticals, Inc. Reports on Clinical Program Status and 2011 First Quarter Results
5/3/2011
-
Lexicon Pharmaceuticals, Inc. to Provide First Quarter 2011 Financial Results
4/26/2011
-
Lexicon Pharmaceuticals, Inc. to Present at the 10th Annual Needham Healthcare Conference
3/30/2011
-
Lexicon Pharmaceuticals, Inc. Appoints Dr. Pablo Lapuerta Chief Medical Officer
3/25/2011
-
Lexicon Pharmaceuticals, Inc. to Present at the Cowen and Company 31st Annual Health Care Conference
3/2/2011
-
Lexicon Pharmaceuticals, Inc. Provides Clinical Pipeline Update and Reports 2010 Fourth Quarter and Full Year Financial Results
2/24/2011
-
Lexicon Pharmaceuticals, Inc. to Report Fourth Quarter and Year End 2010 Financial Results on February 24, 2011
2/15/2011